Abstract:A single atom Gd‐based magnetic resonance imaging (MRI) CA (feGd‐NxC) with concurrently improved relaxivity and stability is fabricated through spatial confined thermal calcination and controllable chemical etching methods. The afforded feGd‐NxC can potentially be utilized as contrast agents both for T1 and T2 weighted MRI, offering self‐confirmative properties for in vivo diagnosis. Gadolinium (Gd)‐based complexes are extensively utilized as contrast agents (CAs) in magnetic resonance imaging (MRI), yet, suffer from potential safety concerns and poor tumor targeting. Herein, as a mimic of Gd complex, single‐atom Gd nanoprobes with r1 and r2 values of 34.2 and 80.1 mM−1 s−1 (far higher than that of commercial Gd CAs) at 3 T are constructed, which possessed T1/T2 dual‐mode MRI with excellent stability and good tumor targeting ability. Specifically, single‐atom Gd is anchored on nitrogen‐doped carbon matrix (Gd‐NxC) through spatial‐confinement method, which is further subjected to controllable chemical etching to afford fully etched bowl‐shape Gd‐NxC (feGd‐NxC) with hydrophilic properties and defined coordination structure, similar to commercial Gd complex. Such nanostructures not only maximized the Gd3+ site exposure, but also are suitable for self‐confirmative diagnosis through one probe with dual‐mode MRI. Moreover, the strong electron localization and interaction between Gd and N atoms afforded feGd‐NxC excellent kinetic inertness and thermal stability (no significant Gd3+ leaching is observed even incubated with Cu2+ and Zn2+ for two months), providing a creative design protocol for MRI CAs.

Oxygen Vacancy Enables Markedly Enhanced Magnetic Resonance Imaging-Guided Photothermal Therapy of a Gd3+-Doped Contrast Agent

Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene Glycol)/arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres As an Enhanced T1 Magnetic Resonance Imaging Contrast Agent.

Gadolinium‐based Contrast Agents for Magnetic Resonance Cancer Imaging

Oxygen Vacancies Enhanced CeO2:Gd Nanoparticles for Sensing a Tumor Vascular Microenvironment by Magnetic Resonance Imaging

Preparation of Mn2+@PolyDOPA-b-polysarcosine Micelle As MRI Contrast Agent with High Longitudinal Relaxivity

High relaxivity Gd3+-based organic nanoparticles for efficient magnetic resonance angiography

Gadolinium(III)-based Polymeric Magnetic Resonance Imaging Agents for Tumor Imaging

A Targeted Nanoglobular Contrast Agent from Host-Guest Self-Assembly for MR Cancer Molecular Imaging.

Single‐Atom Gd Nanoprobes for Self‐Confirmative MRI with Robust Stability

Photoinduced Superhydrophilicity of Gd-Doped TiO 2 Ellipsoidal Nanoparticles Boosts T 1 Contrast Enhancement for Magnetic Resonance Imaging

Enhancing the magnetic relaxivity of MRI contrast agents via the localized superacid microenvironment of graphene quantum dots

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.

Engineering the Surface of Gd2O3 Nanoplates for Improved T1-weighted Magnetic Resonance Imaging

Biodegradable Nanoglobular Magnetic Resonance Imaging Contrast Agent Constructed with Host-Guest Self-Assembly for Tumor-Targeted Imaging.

Gadolinium-based Contrast Agents Built of DO3A-pyridine Scaffold: Precisely Tuning Carboxylate Group for Enhanced Magnetic Resonance Imaging

A Hexanuclear Gadolinium(III)-Based Nanoprobe for Magnetic Resonance Imaging of Tumor Apoptosis

Polydopamine Coated Manganese Oxide Nanoparticles with Ultrahigh Relaxivity As Nanotheranostic Agents for Magnetic Resonance Imaging Guided Synergetic Chemo-/Photothermal Therapy.

Gadolinium(III) Porphyrinoid Phototheranostics.

Single-Atom Gadolinium Nano-Contrast Agents with High Stability for Tumor <i>T</i><sub>1</sub> Magnetic Resonance Imaging

Single-Atom Gadolinium Nano-Contrast Agents with High Stability for Tumor T 1 Magnetic Resonance Imaging

Stimuli-Responsive Biodegradable Hyperbranched Polymer–Gadolinium Conjugates as Efficient and Biocompatible Nanoscale Magnetic Resonance Imaging Contrast Agents